English  |  正體中文  |  简体中文  |  2823020  
???header.visitor??? :  30199521    ???header.onlineuser??? :  1147
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"su y y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-10 of 41  (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2023 Tissue Quality Comparison Between Heparinized Wet Suction and Dry Suction in Endoscopic Ultrasound-Fine Needle Biopsy of Solid Pancreatic Masses: A Randomized Crossover Study Lin, M.-Y.;Wu, C.-L.;Su, Y.-Y.;Huang, C.-J.;Chang, W.-L.;Sheu, B.-S.
國立成功大學 2023 The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan Su, Y.-Y.;Chiang, N.-J.;Chang, J.S.;Wang, Y.-W.;Shen, B.-N.;Li, Y.-J.;Hwang, D.-Y.;Shan, Y.-S.;Chen, L.-T.
臺大學術典藏 2022-08-19T00:20:28Z Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives Su Y.-Y.; Lin Y.-J.; Li C.-C.; CHIUN HSU
臺大學術典藏 2022-03-08T03:44:01Z A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study Su Y.-Y.; Chiu Y.-F.; Li C.-P.; SHIH-HUNG YANG; Lin J.; Lin S.-J.; Chang P.-Y.; Chiang N.-J.; Shan Y.-S.; Ch��ang H.-J.; Chen L.-T.
臺大學術典藏 2022-03-08T03:44:01Z Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients�� experience within a population-based study Chiu T.-J.; Su Y.-Y.; SHIH-HUNG YANG; Li C.-P.; Bai L.-Y.; Chiang N.-J.; Chuang S.-C.; Shan Y.-S.; Chan D.-C.; Chen L.-T.; Yen C.-J.; Peng C.-M.; Chen Y.-Y.; Chen J.-S.; Chou W.-C.
臺大學術典藏 2022-03-08T03:44:01Z Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T.
國立成功大學 2022 Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study Chiang, N.-J.;Tan, K.T.;Bai, L.-Y.;Hsiao, C.-F.;Huang, C.-Y.;Hung, Y.-P.;Huang, C.-J.;Chen, S.-C.;Shan, Y.-S.;Chao, Y.;Huang, Y.-H.;Lee, I.-C.;Lee, P.-C.;Su, Y.-Y.;Chen, S.-J.;Yeh, C.-N.;Chen, L.-T.;Chen, M.-H.
國立成功大學 2022 Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin Chiu, T.-J.;Yang, S.-H.;Chiu, S.-C.;Hsueh, S.-W.;Chiang, N.-J.;Li, C.-P.;Bai, L.-Y.;Cheng, F.-M.;Chuang, S.-C.;Shan, Y.-S.;Chan, D.-C.;Chen, L.-T.;Yen, C.-J.;Peng, C.-M.;Su, Y.-Y.;Chen, Y.-Y.;Chen, J.-S.;Chou, W.-C.
國立成功大學 2022 Semaphorin 6C Suppresses Proliferation of Pancreatic Cancer Cells via Inhibition of the AKT/GSK3/β-Catenin/Cyclin D1 Pathway Hung, Y.-H.;Hsu, S.-H.;Hou, Y.-C.;Chu, P.-Y.;Su, Y.-Y.;Shan, Y.-S.;Hung, W.-C.;Chen, L.-T.
臺大學術典藏 2021-09-17T07:13:03Z Corrigendum to “Morbidity and mortality of very low birth weight infants in Taiwan—Changes in 15 years: A population based study” [Journal of the Formosan Medical Association 115 (2016) 1039–1045](S0929664616303461)(10.1016/j.jfma.2016.10.011) Su Y.-Y.; Wang S.-H.; Chou H.-C.; CHIEN-YI CHEN; Hsieh W.-S.; Tsao P.-N.; Tsou K.-I.; Hsu C.-H.; Mu S.-C.; Lin H.-C.; Huang C.-C.; Hsieh K.-S.; Taiwan Premature Infant Follow-up Network

Showing items 1-10 of 41  (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page